This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Ramos, C. A. et al. Anti-CD30 CAR-T Cell therapy in relapsed and refractory Hodgkin lymphoma. J. Clin. Oncol. https://doi.org/10.1200/JCO.20.01342 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. CAR T cells are active in Hodgkin lymphoma. Nat Rev Clin Oncol 17, 592 (2020). https://doi.org/10.1038/s41571-020-0425-8
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-020-0425-8